Answers are grounded in this paper and cite their sources.
Among antiarrhythmic drugs, only beta-blockers and possibly amiodarone have definitively demonstrated a reduction in arrhythmia-related mortality.
The pharmacological approach is the corner-stone of therapy for arrhythmia because it is non-invasive, convenient and widely available. However, the indications for antiarrhythmic therapy in general, as well as the indications for drug therapy as opposed to non-pharmacological therapeutic methods, are far from clearly defined. Among the existing antiarrhythmic drugs, clear reduction of mortality due to arrhythmia has been shown definitively only with beta-blocking agents and possibly with amiodarone.
No takes yet. Share an insight, caveat, or question.
Camm et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: